
The British Heart Foundation has revealed that around 620,000 people are thought to be at risk of having a faulty …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

